February 16, 2018

February 16, 2018

Biomarker may predict course of metastatic melanoma treated with PD-1 antibodies

Reuters Health- Feb. 15

Dr. Vernon Sondak, chair, Department of Cutaneous Oncology at Moffitt Cancer Center in Tampa, Florida, told Reuters Health, “Oncologists do get several clues as to whether tumor enlargement in the initial weeks of a patient’s immunotherapy treatment is pseudoprogression or the real thing.”


FDA Advisory Committee Nixes Novel Pain Drug

Medscape – Feb. 15

David S. Craig, PharmD, clinical pharmacy specialist, Department of Pharmacy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, for example, told the committee that promethazine is the "wrong choice of antiemetic" because of its risk for central nervous system complications.



Nicole L. Draper Celebrated for Excellence in Medicine

24-7 Press Release – Feb. 15

From 2007 to 2008, she completed a fellowship in oncologic surgical pathology with the school's Moffitt Cancer Center, and from 2008 to 2009 she completed a fellowship in blood banking and transfusion medicine with the Puget Sound Blood Center. 


Satellite centers keep cancer treatment closer to patients' orbit

Building Design & Construction – Feb. 14

Quirk points, by way of example, to the 207,000-sf McKinley Outpatient Treatment facility, a $68 million Skanska project that opened last fall about a mile from H. Lee Moffitt Cancer Center’s campus in Tampa, Fla. “Moffitt saw the need to get out into the marketplace,” says Quirk.


Dr. Locke Discusses the Impact of the ZUMA-1 Trial in NHL

OncLive – Feb. 14

Frederick Locke, MD, a medical oncologist in the Department of Blood and Marrow Transplant at Moffitt Cancer Center, and an assistant professor of oncology at the University of South Florida, discusses the impact of the ZUMA-1 trial for patients with non-Hodgkin lymphoma (NHL).


University Mall developers close to unveiling billion-dollar redevelopment plan

Tampa Bay Business Journal – Feb. 14

To be sure, the mall's location is a prime piece of real estate by any objective measure: It sits next to two economic titans, the University of South Florida and H. Lee Moffitt Cancer Center & Research Institute, and just down the street from Yuengling Brewing Co. and the Museum of Science and Industry. 


Mouse Study Offers New Approach to Combat Side Effect of Stem Cell Transplants, GVHD

Lymphoma News Today – Feb. 14

“An effort to identify selective immune suppression whereby GVHD is reduced and the antitumor activity of the graft is preserved is key to improving the success of blood and marrow transplantation,” Brian C. Betts, MD, lead study author, said in a press release. Betts is associate member of the Blood and Marrow Transplant and Cellular Immunotherapy Department at Moffitt Cancer Center in Tampa, Florida.


PierianDx : Hosts Expert Customer Panel Discussion Regarding Debated CMS National Coverage Decision on NGS Testing

4-Traders – Feb. 14

On February 22 at 2 pm CST, Dr. Nagarajan and Dr. Verma will facilitate a roundtable discussion among representatives from NorthShore University Health System, Moffitt Cancer Center, UVA Health System, the Medical College of Georgia at Augusta University, and the University of Vermont Health System. Also posted to Pharmiweb, WICZ and BioSpace.


Acupuncture Improves Cancer Treatment

KSAT – Feb. 13

 Acupuncturist, Liem Quang Le, DAOM, H. Lee Moffitt Cancer Center says it stimulates the body’s natural ability to heal itself. Also seen on KFDX.


Defining Ponatinib's Role in Ph-Positive ALL

OncLive – Feb. 13

Bijal D. Shah, MD: My big concern is what to do after the ponatinib. That continues to be my concern. I’m one of those stalwarts. I’m still using dasatinib, or Sprycel, and hyper-CVAD induction.


Triple Negative Breast Cancer Treatment Market to Witness a Pronounce Growth by 2025

Open PR – Feb. 13

According to the research article published in Journal of the Moffitt Cancer Center, around 1 million breast cancers are diagnosed globally among them 1.7% of cancer cases are triple-negative cancers. 


Pediatric cancer researchers gather in Tampa to share ideas, and hope for a cure

Twin City Telegraph – Feb. 13

The project offered a new way to spearhead research and development, said Dr. Doug Letson, physician-in-chief at the Moffitt Cancer Center. As a pediatric surgeon, Letson said he was frustrated with the lack of opportunities to research children with cancer.


First look: Inside Amgen’s "next-generation" workspace in Tampa

Tampa Bay Business Journal – Feb. 12

 In addition, Amgen works with Moffitt Cancer Center on drug research and testing.


Study: Only one-quarter of clinicians comfortable with value-based payment program

MM&M – Feb. 12

And grantors have been interested to back such programs. Holland said he and his team conducted a two-year initiative with Celgene at the Moffitt Cancer Center on the treatment of deep vein thrombosis in oncology patients.


Dr. Strosberg on Radiolabeled Somatostatin Analogs in GEP-NETs

OncLive – Feb. 12

Jonathan R. Strosberg, MD, associate professor, Moffitt Cancer Center, discusses the development of radiolabeled somatostatin analogs in the treatment of patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs).


Celyad  to Host Key Opinion Leader Meeting on CAR-T Therapy for the Treatment of Blood Cancers

4-Traders – Feb. 13

The meeting will feature a presentation by Key Opinion Leader Marco Davila, MD, PhD (Moffitt Cancer Center), who will discuss the evolving treatment landscape of CAR-T therapies in development, as well as the unmet medical need for treating patients with blood cancers, including Acute Myeloid Leukemia (AML). Dr. Davila will be available to answer questions at the conclusion of the event.


Photos From the 2018 Gastrointestinal Cancers Symposium, San Francisco

ASCO Post – Feb. 10

Khaldoun Almhanna, MD, MPH, of the H. Lee Moffitt Cancer Center in Tampa, Florida, leads a group of attendees on a poster walk.


10 Top Cancer Experts Reveal What They Do to Prevent the Deadly Disease

Men’s Health – Feb. 10

Philippe Spiess, M.D., a genitourinary oncologist at Moffitt Cancer Center, eats what he calls a “power egg breakfast wrap.” He heats 1/4 cup of frozen spinach in a pan and mixes it with an egg and 200 milliliters (nearly a cup) of egg whites. 


T-Cell Acute Lymphoblastic Leukemia: Impacting Prognosis

OncLive – Feb. 9

Bijal D. Shah, MD: Yes, I’d agree. I will push back a little. I do think it’s along the same lines as B-cell ALL to try and pick up on those NOTCH, RAS, and PTEN mutations. I do think that it was the GMALL (German Multicenter ALL Working Group) experience that demonstrated that opposed to MRD alone, while it does predict for the risk of relapse, if you include this genetic risk assessment you get a broader sense of who’s likely to fare poorly. And so, we do try to build both MRD and genomics into the risk stratification for all the reasons I mentioned before.


Moffitt Cancer Center Spreads Love To Teachers On Valentine’s Day

PublicNow.com – Feb. 9

Cathy Bishop was about to retire after nearly 35 years as a Hillsborough County teacher and elementary school assistant principal when she was diagnosed with stage 3 colon cancer. After surgery and chemotherapy at Moffitt Cancer Center, today she is cancer free.


Florida politicians react to budget deal ending government shutdown

FloridaPolitics.com – Feb. 9

U.S. Rep. Kathy Castor: “Passage of the bipartisan budget deal is particularly important to Tampa Bay area families, veterans and service members.  Medical researchers at Moffitt Cancer Center and the University of South Florida can continue to find the cures of tomorrow and improve treatment of diseases due to the boost in funding for the National Institutes of Health.”


Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.